No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Chromosomes, Human, Pair 11
-
DNA-Binding Proteins / genetics
-
Disease Susceptibility
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Drug Synergism
-
Gene Rearrangement / genetics
-
Histone-Lysine N-Methyltransferase
-
Humans
-
Leukemia, Myeloid / chemically induced*
-
Leukemia, Myeloid / genetics
-
Leukemia, Myeloid / therapy
-
Myeloid-Lymphoid Leukemia Protein
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
-
Proto-Oncogenes*
-
Remission Induction
-
Risk Factors
-
Topoisomerase II Inhibitors*
-
Transcription Factors*
-
Translocation, Genetic / genetics
Substances
-
Antineoplastic Agents
-
DNA-Binding Proteins
-
KMT2A protein, human
-
Topoisomerase II Inhibitors
-
Transcription Factors
-
Myeloid-Lymphoid Leukemia Protein
-
Histone-Lysine N-Methyltransferase